Alzheimer's Disease: Improvement of Visual Memory and Visuoconstructive Performance by Treatment with Picotesla Range Magnetic Fields

References

• Ajuriaguerra J., Muller M., Tissot R. A propos de quelques problemes poses par l'apraxie dans les demences. Encephale 1960; 49: 275–401
   Google Scholar
• Altman H. J., Normile H. J. What is the nature of the role of the serotonergic nervous system in learning and memory: prospects for development of an effective treatment strategie for senile dementia. Neurobiology of Aging 1988; 9: 627–638
   PubMed Web of Science ®Google Scholar
• Altman H. J., Stone W. S., Ogren S. O. Evidence for a possible functional interaction between serotonergic and cholinergic mechanisms in memory retrieval. Behavioral Neural Biology 1987; 48: 49–62
   PubMedGoogle Scholar
• Alvord E. C. The pathology of Parkinsonism: Part II. An interpretation with special reference to other changes in the aging brain. Recent advances in parkinson's disease, F. H. McDowell, C. H. Markham. Davis, Philadelphia 1971
   Google Scholar
• Anderson B. Is alpha-MSH deficiency the cause of Alzheimer's disease?. Medical Hypotheses 1986; 19: 379–385
   PubMed Web of Science ®Google Scholar
• Anninos P. A., Tsagas N., Sandyk R., Derpapas K. Magnetic stimulation in the treatment of partial seizures. International Journal of Neuroscience 1991; 60: 141–171
   PubMed Web of Science ®Google Scholar
• Anton-Tay F., Chou C., Anton S., Wurtman R. J. Brain serotonin concentration: elevation following intraperitoneal administration of melatonin. Science 1968; 162: 277–278
   PubMed Web of Science ®Google Scholar
• Appel S. H. A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism and Alzheimer's disease. Annals of Neurology 1981; 10: 499–505
   PubMed Web of Science ®Google Scholar
• Arai H., Koska K., Iizuka R. Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer's type dementia. Journal of Neurochemistry 1984; 43: 388–393
   PubMed Web of Science ®Google Scholar
• Archer T., Ogren S. O., Johansson C. The acute effects of p-chloroamphetamine on the retention of fear conditioning in the rat: evidence for a role of serotonin in memory consolidation. Neuroscience Letters 1981; 25: 75–81
   PubMed Web of Science ®Google Scholar
• Armstrong S. M., Cassone V. M., Chesworth M. J., Redman J. R., Short R. V. Synchronization of rat circadian rhythms by melatonin. Journal of Neural Transmission 1986; 21(suppl)375–394
   Google Scholar
• Aschoff J., Wever R. The circadian system in man. Handbook of behavioral neurobiology biological rhythms, J. Aschoff. Plenum Press, New York 1981; vol. 4: 311–348
   Google Scholar
• Balaban P. M., Bravarenko N. I., Kuznetzov A. N. Influence of a stationary magnetic field on bioelectric properties of snail neurons. Bioelectromagnetics 1990; 11: 13–24
   PubMed Web of Science ®Google Scholar
• Bawin S. M., Gavalas-Medici R. J., Adey W. R. Effects of modulated very high frequency fields on specific brain rhythms in cats. Brain Research 1973; 58: 365–384
   PubMed Web of Science ®Google Scholar
• Beal M. F., Mazurek M. F., Tran V. T., Chatta G., Bird E. D., Martin J. B. Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease. Science 1985; 229: 289–291
   PubMed Web of Science ®Google Scholar
• Bennett-Levy J. Determinants of performance on the Rey-Osterrieth complex figure test: an analysis, and a new technique for single-case assessment. British Journal of Clinical Psychology 1984; 23: 109–119
   PubMed Web of Science ®Google Scholar
• Bentin S., Silverberg R., Gordon H. W. Asymmetrical cognitive deterioration in demented and parkinson patients. Cortex 1981; 17: 533–544
   PubMed Web of Science ®Google Scholar
• Berardi A., Rainero I., Kaye J. A., May C., Haxby J. V., Grady C. L., Rapoport S. I. Concentration of cerobrospinal fluid alpha-melanocyte stimulating hormone correlates with nonverbal-visual performance in dementia of the Alzheimer type. Annals of Neurology 1988; 24: 159
   Web of Science ®Google Scholar
• Blackman C. F. Stimulation of brain tissue in vitro by extremely low frequency, low intensity, sinusoidal electromagnetic fields. Electromagnetic fields and neurobehavioral function, M. E. O'Connor, R. H. Lovely. Alan R. Liss., New York 1988
   Google Scholar
• Bliss V. L., Heppner F. H. Circadian activity rhythm influenced by near zero magnetic field. Nature 1976; 261: 411–412
   PubMed Web of Science ®Google Scholar
• Boller F., Mizutani T., Roessmann U., Gambetti P. Parkinson disease, dementia, and Alzheimer's disease: clinicopathologic correlations. Annals of Neurology 1980; 7: 329–335
   PubMed Web of Science ®Google Scholar
• Bowen D. M., Allen S. J., Benton J. S., Goodhardt M. J., Hann E. A., Palmer A. M., Sims N. R., Smith C. C. T., Spillane J. A., Esiri M. M., Neary D., Snodown J. S., Wilcock G. K., Davison A. N. Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease. Journal of Neurochemistry 1983; 41: 266–272
   PubMed Web of Science ®Google Scholar
• Brock M. A. Biological clocks and aging. Review of Biological Research in Aging 1985; 2: 445–462
   Google Scholar
• Brooks D. N. Memory and head injury. Journal of Nervous and Mental Disease 1972; 155: 350–355
   PubMed Web of Science ®Google Scholar
• Brown G., Grota L., Bubenik G., Niles L., Tsui H. Physiologic regulation of melatonin. Melatonin, current status and perspectives, N. Birau, W. Schloot, 1981; 29: 95–112, Advances in Biosciences
   Google Scholar
• Campbell S. S., Dawson D. Bright light treatment of sleep disturbance in older subjects. Sleep Research 1991; 20: 448
   Google Scholar
• Cardarelli N. F. The role of a thymus-pineal axis in an immune mechanism of aging. Journal of Theoretical Biology 1990; 145: 397–405
   PubMed Web of Science ®Google Scholar
• Carman J. S., Post R. M., Buswell R., Goodwin F. K. Negative effects of melatonin on depression. American Journal of Psychiatry 1976; 133: 1181–1186
   PubMed Web of Science ®Google Scholar
• Cassone V. M. Melatonin and suprachiasmatic nucleus function. Suprachiasmatic nucleus: The mind's clock, D. C. Klein, R. Y. Moore, S. M. Reppert. Oxford University Press, New York 1991; 309–323
   Google Scholar
• Chang Chui H., Teng E. L., Henderson V. W., Moy A. C. Clinical subtypes of dementia of the Alzheimer type. Neurology 1985; 35: 1544–1550
   PubMed Web of Science ®Google Scholar
• Chuang J. I., Chen S. S., Lin M. T. Melatonin decreases brain serotonin-release, arterial pressure and heart rate in rats. Pharmacology 1993; 47: 91–97
   PubMed Web of Science ®Google Scholar
• Cremer-Bartels G., Krause K., Mitoskas G., Brodersen D. Magnetic field of the earth as additional zeitgeber for endogenous rhythms?. Naturwissenschaften 1984; 71: 567–574
   PubMed Web of Science ®Google Scholar
• Cross A. J., Crow T. J., Johnson J. A., Joseph M. H., Perry E. K., Perry R. H., Blessed G., Tomlinson B. E. Monoamine metabolism in senile dementia of Alzheimer type. Journal of Neurological Sciences 1983; 60: 383–392
   PubMed Web of Science ®Google Scholar
• Cross A. J., Crow T. J., Johnson J. A., Perry E. K., Perry R. H., Blessed G., Tomlinson B. E. Studies on neurotransmitter receptor systems in neocortex and hippocampus in senile dementia of the Alzheimer type. Journal of the Neurological Sciences 1984; 64: 109–117
   PubMed Web of Science ®Google Scholar
• Curcio C. A., Kemper T. Nucleus raphe dorsalis in dementia of the Alzheimer type: neurofibrillary changes and neuronal packing density. Journal of Neuropathology and Experimental Neurology 1984; 43: 359–368
   PubMed Web of Science ®Google Scholar
• Demaine C., Semm P. The avian pineal gland as an independent magnetic sensor. Neuroscience Letters 1985; 62: 119–122
   PubMed Web of Science ®Google Scholar
• Demaine C., Semm P. Magnetic fields abolish nychthemeral rhythmicity of responses of Purkinje cells to the pineal hormone melatonin in the pigeon's cerebellum. Neuroscience Letters 1986; 72: 158–162
   PubMed Web of Science ®Google Scholar
• Direnfeld L. K., Albert M. L., Volicer L., Langlais P. J., Marquis J., Kaplan E. Parkinson's disease. The possible relationship of laterality to dementia and neurochemical findings. Archives of Neurology 1984; 41: 935–941
   PubMed Web of Science ®Google Scholar
• Dixey R., Rein G. (3H) Noradrenaline release potentiated in a clonal cell line by low intensity pulsed magnetic fields. Nature 1982; 206: 253–256
   Google Scholar
• Dogovic C., Leysen J. E., Wauquier A. Melatonin modulates the sensitivity of 5-hydroxy-tryptamine-2 receptor-mediated sleep-wakefulness in the rat. Neuroscience Letters 1989; 104: 320–325
   PubMed Web of Science ®Google Scholar
• Dongen P. A. M.V. The human locus coeruleus in neurology and psychiatry (Parkinson's, lewy body, Hallervorden-Spatz, Alzheimer's and Korsakoff's disease, presenile dementia, schizophrenia, affective disorders, psychosis). Progress in Neurobiology 1981; 17: 97–139
   PubMedGoogle Scholar
• Duffy F. H., Albert M. S., McAnulty G. Brain electrical activity in patients with presenile and senile dementia of the Alzheimer's type. Annals of Neurology 1984; 16: 439–448
   PubMed Web of Science ®Google Scholar
• Ebinger G., Bruyland M., Martin J. J., Herregodts P., Cras P., Michotte Y., Gomme L. Distribution of biogenic amines and their catabolites in brains from patients with Alzheimer's disease. Journal of Neurological Sciences 1987; 77: 267–283
   PubMed Web of Science ®Google Scholar
• Epelbaum J., Ruberg M., Moyse E., Javoy-Agid F., Dubois B., Agid Y. Somatostatin and dementia in Parkinson's disease. Brain Research 1983; 278: 376–379
   PubMed Web of Science ®Google Scholar
• Erlich S. S., Apuzzo M. L. J. The pineal gland anatomy, physiology, and clinical significance. Journal of Neurosurgery 1985; 63: 321–341
   PubMed Web of Science ®Google Scholar
• Fekete M., Van Ree J. M., Niesink R. J. M., De Wied D. Disrupting circadian rhythms in rats induces retrograde amnesia. Physiology & Behavior 1985; 34: 883–887
   PubMed Web of Science ®Google Scholar
• Filley C. M., Kelly J., Heaton R. K. Neuropsychologic features of early and late-onset Alzheimer's disease. Archives of Neurology 1986; 43: 574–576
   PubMed Web of Science ®Google Scholar
• Forno L. S., Norville R. L. Synaptic morphology in the human locus coeruleus. Acta Neuropathologica 1981; 53: 7–14
   PubMed Web of Science ®Google Scholar
• Forno L. S., Barbour P. J., Norville R. L. Presenile dementia with Lewy bodies and neurofibrillary tangles. Archives of Neurology 1978; 35: 818–822
   PubMedGoogle Scholar
• Foster N. L., Chase T. N., Fedio P. Alzheimer's disease: focal cortical changes shown by positron emission tomography. Neurology 1983; 33: 961–965
   PubMed Web of Science ®Google Scholar
• Friedland R. P., Koss E., Haxby J. V. Alzheimer's disease: clinical and biological heterogeneity. Annals of Internal Medicine 1988; 109: 298–311
   PubMed Web of Science ®Google Scholar
• Gaffori O., Van Ree J. M. Serotonin and antidepressant drugs antagonize melatonin-induced behavioural changes after injection into the nucleus accumbens of rats. Neuropharmacology 1985; 24: 211–244
   PubMed Web of Science ®Google Scholar
• Gottfries C. G. Disturbance of the 5-hydroxytryptamine metabolism in brains from patients with Alzheimer's disease. Journal of Neural Transmission 1990; 30(suppl)33–43
   Google Scholar
• Grad B. R., Rozencwaig R. The role of melatonin and serotonin in aging: update. Psychoneuroendocrinology 1993; 18: 283–295
   PubMed Web of Science ®Google Scholar
• Guyton A. C. Basic neuroscience: anatomy and physiology. W. B. Saunders Company, Philadelphia 1991; 250–253
   Google Scholar
• Hakim A. M., Mathieson G. Dementia in Parkinson's disease: a neuropathologic study. Neurology 1979; 29: 1209–1214
   PubMed Web of Science ®Google Scholar
• Haxby J. V., Grady C. L., Duara R. Relations among age, visual memory, and resting cerebral metabolism in 40 healthy men. Brain & Cognitiona 1986; 5: 412–427
   PubMed Web of Science ®Google Scholar
• Healy D. Rhythm and blues. Neurochemical, neuropharmacological and neuropsychological implications of a hypothesis of circadian rhythm dysfunction in the affective disorders. Psychopharmacology 1987; 93: 271–285
   PubMed Web of Science ®Google Scholar
• Henderson V. W., Mack W., Williams B. W. Spatial disorientation in Alzheimer's disease. Archives of Neurology 1989; 46: 391–394
   PubMed Web of Science ®Google Scholar
• Hirano A., Zimmerman H. Alzheimer's neurofibrillary changes: a topographic study. Archives of Neurology 1962; 7: 227–242
   PubMedGoogle Scholar
• Holloway F. A., Wansley R. A. Multiple retention deficits at periodic intervals after passive avoidance learning. Science 1973a; 180: 208–210
   PubMed Web of Science ®Google Scholar
• Holloway F. A., Wansley R. A. Multiple retention deficits after active and passive avoidance learning. Behavioral Biology 1973b; 9: 1–14
   PubMedGoogle Scholar
• Hozumi S., Okawa M., Mishima K., Hishikawa Y., Hori H., Takahashi K. Phototherapy for elderly patients with dementia and sleep-wake rhythm disorders–a comparison between morning and evening light exposure. Japanese Journal of Neurology & Psychiatry 1990; 44: 813–814
   Google Scholar
• Hughes A. J., Daniel S. E., Blankson S., Lees A. J. A clinicopathologic study of 100 cases of Parkinson's disease. Archives of Neurology 1993; 50: 140–148
   PubMed Web of Science ®Google Scholar
• Ingram D. K., London E. D., Reynolds M. A. Circadian rhythmicity and sleep: effects of aging in laboratory animals. Neurobiology of Aging 1982; 3: 287–297
   PubMed Web of Science ®Google Scholar
• Jaffe R. A., Laszewski B. L., Carr D. B., Phillips R. D. Chronic exposure to a 60-Hz electric field: effects on synaptic transmission and peripheral nerve function in the rat. Bioelectromagnetics 1980; 1: 131–147
   PubMedGoogle Scholar
• Kaiya H., Tanaka T., Takeuchi K., Morita K., Adachi S., Shirakawa H., Ueki H., Namba M. Decreased level of beta-endorphin-like immunoreactivity in cerebrospinal fluid of patients with senile dementia of Alzheimer type. Life Sciences 1983; 33: 1039–1043
   PubMed Web of Science ®Google Scholar
• Kaplan E. The process approach to neuropsychological assessment of psychiatric patients. Journal of Neuropsychiatry 1990; 2: 72–87
   PubMedGoogle Scholar
• Kastin A. J., Redding T. W., Schally A. V. MSH activity in rat pituitaries after pinealectomy. Proceedings of the Society for Experimental Biology and Medicine 1967; 124: 1275–1277
   PubMed Web of Science ®Google Scholar
• Kastin A. J., Viosca S., Nair R. M. G., Schally A. V., Miller M. C. Interactions between pineal, hypothalamus and pituitary involving melatonin, MSH release-inhibiting factor and MSH. Endocrinology 1972; 91: 1323–1328
   PubMed Web of Science ®Google Scholar
• Katzman R. Alzheimer's disease. The New England Journal of Medicine 1986; 314: 964–973
   PubMed Web of Science ®Google Scholar
• Kaye J. A., May C., Daly E., Atack J. R., Sweeney D. J., Luxenberg J. S., Kay A. D., Kaufman S., Milstien S., Friedland R. P., Rapoport S. I. Cerebrospinal fluid monoamine markers are decreased in dementia of the Alzheimer type with extrapyramidal features. Neurology 1988; 38: 554–557
   PubMed Web of Science ®Google Scholar
• Kirk A., Kertesz A. Hemispheric contributions to drawing. Neuropsychologia 1989; 27: 881–886
   PubMed Web of Science ®Google Scholar
• Kirk A., Kertesz A. On drawing impairment in Alzheimer's disease. Archives of Neurology 1991; 48: 73–77
   PubMed Web of Science ®Google Scholar
• Kloeden P. E., Rossler R., Rossler O. E. Does a centralized clock for ageing exist?. Gerontology 1990; 36: 314–322
   PubMed Web of Science ®Google Scholar
• Kolb B., Whishaw I. Q. Fundamentals of human neuropsychology. W. H. Freeman and Company, New York 1990; 455–456, 233–236 & 463–501
   Google Scholar
• Korczyn A. D., Inzelberg R., Treves T., Neufeld M., Reider I., Rabey P. M. Dementia of Parkinson's disease. Advances in neurology, M. D. Yahr, K. J. Bergmann. Raven Press, New York 1986; 399–403
   Google Scholar
• Koulu M., Lammintausta R. Effect of melatonin on L-tryptophan and apomorphine stimulated growth hormone secretion in man. Journal of Endocrinology & Metabolism 1979; 49: 70–72
   Google Scholar
• Kurlan R., Como P. Drug-induced Alzheimerism. Archives of Neurology 1988; 45: 356–357
   PubMedGoogle Scholar
• Laudon M., Zisapel N. Impact of circulating estradiol on melatonin binding sites in discrete areas of the female rat brain. Brain Research 1987; 402: 146–150
   PubMed Web of Science ®Google Scholar
• Laudon M., Nir I., Zisapel N. Melatonin receptors in discrete brain areas of the male rat. Impact of aging on density and on circadian rhythmicity. Neuroendocrinology 1988; 48: 577–583
   PubMed Web of Science ®Google Scholar
• Lawlor B. A. Serotonin and Alzheimer's disease. Psychiatric Annals 1990; 20: 567–570
   Web of Science ®Google Scholar
• Lebrum Y., Hoops R. Intelligence and aphasia. Swets & Zeitlinger, B. V., Amsterdam 1974
   Google Scholar
• Leverenz J., Sumi S. M. Parkinson's disease in patients with Alzheimer's disease. Archives of Neurology 1986; 43: 662–664
   PubMed Web of Science ®Google Scholar
• Lezak M. D. Neuropsychological assessment, second Edition. Oxford University Press., New York 1983; 68–69, 395–402; 444–447
   Google Scholar
• Lott J. R., McCain H. B. Some effects of continuous and pulsating electric fields on brain wave activity in rats. International Journal of Biometerology 1973; 17: 221–225
   PubMedGoogle Scholar
• Lydic R., Schoene W. C., Czeisler C. A., Moore-Ede M. Suprachiasmatic region of the human hypothalamus: homolog to the primate circadian pacemaker?. Sleep 1980; 2: 355–361
   PubMed Web of Science ®Google Scholar
• Mann D. M. A., Yates P. O., Hawkes J. The noradrenergic system in Alzheimer and multiinfarct dementias. Journal of Neurology, Neurosurgery and Psychiatry 1982; 45: 113–119
   PubMed Web of Science ®Google Scholar
• Martin P. R., Adinoff B., Eckardt M. I., Stapleton J. M., Bone G. A. H., Rubinow D. R., Lane E. A., Linnoila M. Effective pharmacotherapy of alcoholic amnestic disorder with fluvoxamine. Archives of General Psychiatry 1989; 46: 617–621
   PubMed Web of Science ®Google Scholar
• Mayeux R., Stern Y., Spanton S. A. Heterogeneity in dementia of the Alzheimer type: evidence of subgroups. Neurology 1985; 35: 453–461
   PubMed Web of Science ®Google Scholar
• McEntee W. J., Crook T. H. Serotonin, memory, and the aging brain. Psychopharmacology 1991; 103: 143–149
   PubMed Web of Science ®Google Scholar
• McFie J., Zangwill O. L. Visual constructive disabilities associated with lesion of the left cerebral hemisphere. Brain 1960; 83: 243–260
   Web of Science ®Google Scholar
• McFie J., Piercy M. F., Zangwill O. L. Visual spatial agnosia associated with lesions of the right cerebral hemisphere. Brain 1950; 73: 167–190
   PubMed Web of Science ®Google Scholar
• Mildworf B., Globus M., Melamed E. Patterns of cognitive impairment in patients with Alzheimer's disease and Parkinson's disease: are they similar or different. Alzheimer's and parkinson's disease: strategies for research and development, A. Fisher, I. Hanin, C. Lachman. Plenum Press, New York 1986; 135–140
   Google Scholar
• Miller L. H., Kastin A. J., Sandman C. A., Fink M., Van Veen W. J. Polypeptide influence on attention, memory and anxiety in man. Pharmacology Biochemistry & Behavior 1974; 2: 663–668
   PubMed Web of Science ®Google Scholar
• Milner B. Some effects of frontal lobectomy in man. The frontal granular cortex and behavior, J. M. Warren, K. Akert. McGraw-Hill, New York 1964
   Google Scholar
• Mirmiran M., Swaab D. F., Witing W., Honnebier M. B. O.M., van Gool W. A., Eikelenboom P. Biological clocks in development, aging and Alzheimer's disease. Brain Dysfunction 1989; 2: 57–66
   Google Scholar
• Molsa P. K., Marttila R. J., Rinne U. K. Extrapyramidal signs in Alzheimer's disease. Neurology 1984; 34: 1114–1116
   PubMed Web of Science ®Google Scholar
• Mondadori C. Pharmacological modulation of memory: trends and problems. Acta Neurologica Scandnavica 1981; 89(suppl)129–143
   Google Scholar
• Mouradian M. M., Farah J. M., Mohr E., Fabbrini G., O'Donohue T. L., Chase T. N. Spinal fluid CRF reduction in Alzheimer's disease. Neuropeptides 1986; 8: 393–400
   PubMed Web of Science ®Google Scholar
• Nair N. V. P., Hariharasubramanian N., Pilapil C., Isaac I., Thavundayil J. X. Plasma melatonin–an index of brain aging in humans?. Biological Psychiatry 1986; 21: 141–150
   PubMed Web of Science ®Google Scholar
• O'Donohue T. L., Dorsa D. M. The opiomelanotrophinergic neuronal and endocrine systems. Peptides 1982; 3: 353–395
   PubMed Web of Science ®Google Scholar
• Okawa M., Mishima K., Shimizu T., Iijima S., Hishikawa Y., Hozumi S., Hori H. Sleep-waking rhythm disorders and their phototherapy in elderly patients with dementia. Japanese Journal of Psychiatry & Neurology 1989; 43: 293–295
   Google Scholar
• Olcese J., Reuss S., Semm P. Geomagnetic field detection in rodents. Life Sciences 1988; 42: 605–613
   PubMed Web of Science ®Google Scholar
• Oleskevich S., Descartes L. Quantified distribution of the serotonin innervation in adult rat hippocampus. Neuroscience 1990; 34: 19–33
   PubMed Web of Science ®Google Scholar
• Ossenkopp K. P., Cain D. P. Inhibitory effects of powerline-frequency (60-Hz) magnetic fields on pentylenentetrazol-induced seizures and mortality in rats. Behavioural Brain Research 1991; 44: 211–216
   PubMed Web of Science ®Google Scholar
• Osterrieth P. A. Le test de copie d'une figure complexe. Archives of Psychology 1944; 30: 206–356
   Google Scholar
• Oxenkrug G. F., McIntyre I. M., Gershon S. Effects of pinealectomy and aging on the serum corticosterone circadian rhythms in rats. Journal of Pineal Research 1984; 1: 181–185
   PubMed Web of Science ®Google Scholar
• Palmer A. M., Francis P. T., Benton J. S., Sims N. R., Mann D. M. A., Neary D., Snowden J. S., Bowen D. M. Presynaptic serotonergic dysfunction in patients with Alzheimer's disease. Journal of Neurochemistry 1987; 48: 8–15
   PubMed Web of Science ®Google Scholar
• Perez F. I., Rivera V. M., Meyer J. S., Gay J. R. A., Taylor R. L., Mathew N. T. Analysis of intellectual and cognitive performance in patients with multiinfarct dementia, vertebrobasillar insufficiency with dementia and Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry 1975; 38: 533–540
   PubMed Web of Science ®Google Scholar
• Perry E. K. Cortical neurotransmitter chemistry in Alzheimer's disease. Pharmacology: the third generation in progress, H. Meltzer. Raven Press, New York 1987
   Google Scholar
• Pierpaoli W., Maestroni J. M. Melatonin: a principal neuroimmunoregulatory and anti-stress hormone: its anti-aging effects. Immunology Letters 1987; 16: 355–362
   PubMed Web of Science ®Google Scholar
• Pierpaoli W., Yi C., Dall'ara A. Aging-postponing effects of circadian melatonin: experimental evidence, significance and possible mechanisms. International Journal of Neuroscience 1990; 51: 339–340
   PubMed Web of Science ®Google Scholar
• Prinz P. N., Vitaliano M. V., Vitiello J., Bokan J., Raskind M., Peskind E., Gerber C. Sleep, EEG and mental function changes in senile demenetia of the Alzheimer's type. Neurobiology of Aging 1982a; 3: 361–370
   PubMed Web of Science ®Google Scholar
• Prinz P. N., Peskind E. R., Vitaliano P. P., Raskind M. A., Eisdorfer C., Zemcuznikov N., Gerber C. Changes in the sleep and waking EEGs of nondemented and demented elderly subjects. Journal of the American Geriatric Society 1982b; 30: 86–93
   PubMed Web of Science ®Google Scholar
• Rainero I., May M. D., Kaye J. A., Friedland R. P., Rapoport S. I. CSF alpha-MSH in dementia of the Alzheimer type. Neurology 1988; 38: 1281–1284
   PubMed Web of Science ®Google Scholar
• Ramier A. M., Hecan H. Role respectif des atteintes frontales et de la lateralisation lesionnelle dans les deficits de la “fluence verbale.”. Revue de Neurologie 1970; 123: 17–22
   PubMed Web of Science ®Google Scholar
• Reiter R. J. The ageing pineal gland and its physiological consequences. BioEssays 1992; 14: 169–175
   PubMed Web of Science ®Google Scholar
• Renfrew J. W., May C., Tamarkin L. Circadian rhythms in Alzheimer's disease. Neurosciences Abstracts 1987; 1: 322
   Google Scholar
• Rey A. L'examen psychologique dans les cas d'encephalopathie traumatique. Archives of Psychology 1942; 28: 286–340
   Google Scholar
• Romijn H. J. The pineal, a tranquillizing organ?. Life Sciences 1978; 23: 2257–2274
   PubMed Web of Science ®Google Scholar
• Rosen A. D. Magnetic field influence on acetylcholine release at the neuromuscular junction. American Journal of Physiology 1992; 262: C1418–C1422, (cell physiol.31)
   PubMed Web of Science ®Google Scholar
• Rosen A. D., Lubowsky J. Magnetic fields influence on central nervous system function. Experimental Neurology 1987; 95: 679–687
   PubMed Web of Science ®Google Scholar
• Rosen A. D., Lubowsky J. Modification of spontaneous unit discharge in the lateral geniculate body by a magnetic field. Experimental Neurology 1990; 108: 261–265
   PubMed Web of Science ®Google Scholar
• Rosenblum W. I., Ghatak N. R. Lewy bodies in the presence of Alzheimer's disease. Archives of Neurology 1979; 36: 170–171
   PubMedGoogle Scholar
• Rozencwaig R., Grad B. R., Ochoa J. The role of melatonin and serotonin in aging. Medical Hypotheses 1987; 23: 337–352
   PubMed Web of Science ®Google Scholar
• Rusovan A., Kanje M. D600, a Ca2+ antagonist, prevents stimulation of nerve regeneration by magnetic fields. NeuroReport 1992; 3: 813–814
   PubMed Web of Science ®Google Scholar
• Sandyk R. Possible role of pineal melatonin in the mechanism of aging. International Journal of Neuroscience 1990; 52: 85–92
   PubMed Web of Science ®Google Scholar
• Sandyk R. Weak magnetic fields as a novel therapeutic modality in Parkinson's disease. International Journal of Neuroscience 1992a; 66: 1–15
   PubMed Web of Science ®Google Scholar
• Sandyk R. Magnetic fields in the therapy of parkinsonism. International Journal of Neuroscience 1992b; 66: 209–235
   PubMed Web of Science ®Google Scholar
• Sandyk R. The effects of picotesla range magnetic fields on perceptual organization and visual memory in parkinsonism. International Journal of Neuroscience 1993; 73: 207–219
   PubMed Web of Science ®Google Scholar
• Sandyk R., Derpapas K. Further observations on the unique efficacy of picotesla magnetic fields in Parkinson's disease. International Journal of Neuroscience 1993; 70: 233–254
   PubMedGoogle Scholar
• Sandyk R., Iacono R. P. Rapid improvement of visuoperceptive functions by picotesla range magnetic fields in Parkinson's disease. International Journal of Neuroscience 1993a; 69: 167–183
   PubMedGoogle Scholar
• Sandyk R., Iacono R. P. Reversal of visual neglect in Parkinson's disease by treatment with picotesla magnetic fields. International Journal of Neuroscience 1993b; 73: 93–107
   PubMedGoogle Scholar
• Sandyk R., Anninos P. A., Tsagas N. Age related disruption of circadian rhythms: possible relationship to memory impairment and implications for therapy with magnetic fields. International Journal of Neuroscience 1991; 59: 259–262
   PubMed Web of Science ®Google Scholar
• Satlin A., Volicer L., Ross V., Herz L., Campbell S. Bright light treatment of behavioral and sleep disturbances in patients with Alzheimer's disease. American Journal of Psychiatry 1992; 149: 1028–1032
   PubMed Web of Science ®Google Scholar
• Semm P. Neurobiological investigations on the magnetic sensitivity of the pineal gland in rodents and pigeons. Comparative Biochemistry and Physiology 1983; 76A: 683–689
   Web of Science ®Google Scholar
• Semm P., Schneider T., Vollrath L. Effects of an earth-strength magnetic field on electrical activity of pineal cells. Nature 1980; 288: 607–608
   PubMed Web of Science ®Google Scholar
• Sjogren T., Sjogren H., Lindgren A. G. H. Morbus Alzheimer and morbus Pick. Acta Psychiatrica Neurologica Scandinavica 1952; 82(suppl)1–152
   Google Scholar
• Skene D. J., Vivien-Roels B., Sparks D. L., Hunsaker J. C., Pevet P., Ravid D., Swaab D. F. Daily variation in the concentration of melatonin and 5-methoxytryptophol in the human pineal gland: effect of age and Alzheimer's disease. Brain Research 1990; 528: 170–174
   PubMed Web of Science ®Google Scholar
• Smythe G. A., Lazarus L. Growth hormone response to melatonin in man. Science 1974a; 184: 1373–1374
   PubMed Web of Science ®Google Scholar
• Smythe G. A., Lazarus L. Suppression of HGH secretion by melatonin and cyproheptadine. Journal of Clinical Investigations 1974b; 54: 116–121
   PubMed Web of Science ®Google Scholar
• Soininen H., MacDonald E., Rekonen M., Riekkinen P. J. Homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid of patyients with senile dementia of the Alzheimer type. Acta Neurologica Scandinavica 1981; 64: 101–107
   PubMed Web of Science ®Google Scholar
• Souetre E., Salvati E., Krebs B., Belugou J. L., Darcourt G. Abnormal melatonin response to 5-methoxypsoralen in dementia. American Journal of Psychiatry 1989; 146: 1037–1040
   PubMed Web of Science ®Google Scholar
• Sroka H., Elizan T. S., Yahr M. D., Burger A., Mendoza M. R. Organic mental syndrome and confusional states in Parkinson's disease. Relationship to computerized tomographic signs of cerebral atrophy. Archives of Neurology 1981; 38: 339–342
   PubMedGoogle Scholar
• Stankov B., Fraschini F., Reiter R. J. Melatonin binding sites in the central nervous system. Brain Research 1991; 16: 245–256
   Web of Science ®Google Scholar
• Sulkava R., Haltia M., Paetau A. Accuracy of clinical diagnosis in primary degenerative dementia: correlation with neuropathological findings. Journal of Neurology, Neurosurgery and Psychiatry 1983; 46: 9–13
   PubMed Web of Science ®Google Scholar
• Swaab D. F., Fliers E., Partiman T. S. The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. Brain Research 1985; 342: 37–44
   PubMed Web of Science ®Google Scholar
• Swaab D. F., Roozendaal B., Ravid R., Velis D. N., Gooren L., Williams R. S. Suprachiasmatic nucleus in aging, Alzheimer's disease, transsexuality and Prader-Willi syndrome. Progress in brain research, E. R. de Kloet, V. M. Wiegant, D. de Wied. Elsevier, Holland 1987; vol. 72: 301–310
   Google Scholar
• Tapp W. N., Holloway F. A. Phase shifting circadian rhythms produces retrograde amnesia. Science 1981; 211: 1056–1058
   PubMed Web of Science ®Google Scholar
• Taylor E. M. The appraisal of children with cerebral deficits. Harvard University Press., Cambridge, Mass 1959
   Google Scholar
• Taylor L. B. Localization of cerebral lesions by psychological testing. Clinical Neurosurgery 1969; 16: 269–287
   PubMedGoogle Scholar
• Terry R. D., Katzman R. Senile dementia of the Alzheimer type. Annals of Neurology 1983; 14: 497–506
   PubMed Web of Science ®Google Scholar
• Touitou Y., Fevre M., Bogdan A., Reinberg A., De Prins J., Beck H., Touitou C. Patterns of plasma melatonin with ageing and mental condition: stability of nyctohemeral rhythms and differences in seasonal variations. Acta Endocrinologica 1984; 106: 145–151
   PubMedGoogle Scholar
• Wansley R. A., Holloway F. A. Multiple retention deficits following one-trial appetitive training. Behavioral Biology 1975; 14: 135–149
   PubMedGoogle Scholar
• Webb W. B. Sleep in older persons: sleep structures of 50-to 60-year-old men and women. Journal of Gerontology 1982; 37: 581–586
   PubMedGoogle Scholar
• Weintraub S., Mesulam M. M. Mental state assessment of young and elderly adults in behavioral neurology. Principles of behavioral neurology, M. M. Mesulam. F. A. Davis Company., Philadelphia 1985; 71–123
   Google Scholar
• Welker H. A., Semm P., Willig R. P., Commentz J. C., Wiltschko W., Vollrath L. Effects of an artificial magnetic field on serotonin N-acetyltransferase activity and melatonin content of the rat pineal gland. Experimental Brain Research 1983; 50: 426–432
   PubMed Web of Science ®Google Scholar
• Wever R. Einfluss Schwacher Elektro-magnetischer Felder auf die Circadiane Periodik des Menschen. Naturwissenschaften 1968; 55: 29–32
   PubMed Web of Science ®Google Scholar
• Wilson B. W., Anderson L. E., Hilton D. I., Phillips R. D. Chronic exposure to 60-Hz electric field: effects on pineal function in the rat. Bioelectromagnetics 1981; 2: 371–380
   PubMed Web of Science ®Google Scholar
• Wilson B. W., Chess E. K., Anderson L. E. 60-Hz electric field effects on pineal melatonin rhythms: time course for onset and recovery. Bioelectromagnetics 1986; 7: 239–242
   PubMed Web of Science ®Google Scholar
• Wilson B. W. Chronic exposure to ELF fields may induce depression. Bioelectromagnetics 1988; 9: 195–205
   PubMed Web of Science ®Google Scholar
• Wisniewski H. M. Clinical, pathological and biochemical aspects of Alzheimer's disease. Alzheimer's and Parkinson's diseases: strategies for research and development, A. Fisher, I. Hanin, C. Lachman. Plenum Press, New York 1986; 25–36
   Google Scholar
• Wolf-Klein G. P., Silverstone F. A., Levy A. P., Brod M. S. Screening for Alzheimer's disease by clock drawing. Journal of the American Geriatric Society 1989; 37: 730–734
   PubMed Web of Science ®Google Scholar
• Wood F. B., Ebert V., Kinsbourne M. The episodic-semantic memory distinction in memory and amnesia: clinical and experimental observations. Human memory and amnesia, L. Cermak. Lawrence Erlbaum Associates, Hillsdale, NJ 1982; 167
   Google Scholar
• Yagishita S., Itoh Y., Amano N., Nakano T. Atypical senile dementia with widespread Lewy type inclusion body in the cerebral cortex. Acta Neuropathologica 1979; 49: 187–191
   Web of Science ®Google Scholar
• Zangwill O. L. Psychological deficits associated with frontal lobe lesions. International Journal of Neurology 1966; 5: 395–402
   Google Scholar
• Zeise M. L., Semm P. Melatonin lowers excitability of guinea pig hippocampal neurons in vitro. Journal of Comparative Physiology 1985; 157: 23–29
   PubMed Web of Science ®Google Scholar